lunedì, 30 novembre 2020
Medinews
2 Ottobre 2018

Regulatory information – adjusted fees for pharmacovigilance applications from 18 October 2018

September 28, 2018 – The European Medicines Agency (EMA) would like to inform applicants and marketing authorisation holders that adjusted fees for pharmacovigilance applications are expected to come into effect as of 18 October 2018. The European Commission has adopted a regulation adjusting the pharmacovigilance fees payable to the Agency with reference to the inflation rate in the European Union for the previous year. The 2017 inflation rate was 1.7%. Following a … (leggi tutto)

TORNA INDIETRO